Neurological Disorder Drugs Market Research Report and Forecast Neurological Disorder Drugs Market - Europe Indust | Page 2

The market for neurological disorder drugs has been extensively analyzed based on
their usefulness, effectiveness, sales revenue and geographic presence. The market
size and forecast in terms of US$ Mn for each disorder, drug class, distribution
channel as well as geographic regions has been provided for the period from 2016
to 2024. This report on the neurological disorder drugs market also provides the
compound annual growth rate (CAGR %) for each market segment for the forecast
period from 2016 to 2024, considering 2015 as the base year.
Europe Neurological Disorder Drugs Market: Regional Outlook
Geographically, the neurological disorder drugs market has been segmented into 10
major regions: Germany, France, Italy, Spain, U.K., Russia, Switzerland, Netherlands,
Poland and Rest of Europe. The market size and forecast for each of these regions
have been provided for the period from 2016 to 2024, along with CAGR (%) for the
forecast period from 2016 to 2024. The research study also incorporates the
competitive scenario in these regions.
Get accurate market forecast and analysis on the Neurological Disorder
Drugs market. Request a sample to stay abreast on the key trends
impacting this market.
http://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=17567
Key Players Mentioned in this Report are:
A list of recommendations has been provided for new entrants as well as existing
players to help establish a strong presence in the market and increase market
share. The report also profiles major players in the neurological disorder drugs
market based on various attributes such as company overview, financial overview,
business strategies, product portfolio and recent developments. Major players
profiled in this report include Merck & Co., Boehringer Ingelheim GmbH, Bayer AG,
Astra Zeneca, F-Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd.,
Novartis AG, and GlaxoSmithKline plc.
The Europe Neurological Disorder Drugs market is segmented as follows:
Europe Neurological Disorder Drugs Market Revenue, by Disorder
Epilepsy
Alzheimer’s disease
Parkinson’s disease
Multiple Sclerosis
Cerebrovascular disease
Others